Food and Drug Administration (FDA). The nationwide recall involves multiple dosage strengths of Levothyroxine Sodium Tablets packaged in 10-count blister packs. Levothyroxine Sodium Tablets Recall Details and Classifications According to the FDA, the recall was initiated on July 13 and designated as a Class II on July 17. A Class II designation indicates that the … Read more
Food and Drug Administration, according to Gray News. Designed for adults and children aged 12 and older, the single tablet combines two of the most widely used OTC pain relievers in the United States to offer up to 12 hours of relief for minor aches and pains. FDA Approval Details for Tylenol with Naproxen The … Read more
Levothyroxine sodium tablets distributed by Major Pharmaceuticals have been pulled from shelves nationwide in a Class II recall announced by the Food and Drug Administration. According to Prevention, certain lots of the widely prescribed medication are “subpotent,” meaning they may fail to deliver the full prescribed dose required by patients managing an underactive thyroid or … Read more
According to the U.S. Food and Drug Administration (FDA), Unique Pharmaceutical Laboratories is recalling nationwide lots of 5-mg cetirizine hydrochloride tablets—an over-the-counter antihistamine commonly sold as a generic version of Zyrtec—due to cross-contamination with ranitidine, a medication formerly marketed as Zantac used for heartburn and indigestion. The mix-up poses life-threatening anaphylaxis risks for individuals with … Read more
An advisory committee voted narrowly on Thursday to recommend that the Food and Drug Administration reclassify four popular peptide therapies, potentially allowing compounding pharmacies to legally dispense the unapproved substances. According to federal proceedings, the panel’s eight-to-six vote with one abstention followed an 11-hour meeting regarding the substances BPC-157, KPV, and TB-500, while a fourth … Read more
Researchers at Yale University found that patients can obtain GLP-1 prescriptions from online platforms in as little as five minutes using fake profiles, raising significant concerns about the level of clinical oversight in direct-to-consumer healthcare. A study published July 6 in the JAMA medical journal revealed that 45 out of 49 websites tested issued prescriptions … Read more
An unidentified 79-year-old patient gained access to the experimental obesity drug retatrutide through the FDA’s compassionate use pathway, according to reports from STAT News and The New Republic. While speculation persists regarding the patient’s identity, federal agencies have declined to confirm if the individual is former President Donald Trump. The drug was requested in April … Read more
Health authorities in Victoria have issued an urgent alert after six people were hospitalized with acute liver toxicity linked to the use of an unapproved, black-market injectable peptide marketed as “retatrutide.” Medical experts, including specialists at the Victorian Liver Transplant Unit, warn that products sold online or through informal channels are unregulated, counterfeit, and pose … Read more
The U.S. Food and Drug Administration (FDA) has granted emergency use authorization for nitenpyram, a generic medication, to treat New World screwworm infestations in cats and dogs. Previously approved for flea control, the drug serves as a rapid-response treatment for the flesh-eating parasite following recent confirmed cases in Texas cattle and a New Mexico dog, … Read more
The Tug-of-War Between Politics and Public Health The revolving door of leadership at the U.S. Food and Drug Administration (FDA) is more than just a series of personnel changes; it is a symptom of a deeper systemic tension. When the heads of the Center for Drug Evaluation and Research (CDER) and the Commissioner’s office shift … Read more